- Home
- ALLR vs SPRC Comparison
ALLR vs SPRC Comparison
Compare ALLR & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- SPRC
- Stock Information
- Founded
- ALLR 2004
- SPRC 2004
- Country
- ALLR United States
- SPRC Israel
- Employees
- ALLR N/A
- SPRC N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- ALLR Health Care
- SPRC Health Care
- Exchange
- ALLR Nasdaq
- SPRC Nasdaq
- Market Cap
- ALLR 4.0M
- SPRC 3.5M
- IPO Year
- ALLR N/A
- SPRC N/A
- Fundamental
- Price
- ALLR $0.82
- SPRC $0.30
- Analyst Decision
- ALLR
- SPRC
- Analyst Count
- ALLR 0
- SPRC 0
- Target Price
- ALLR N/A
- SPRC N/A
- AVG Volume (30 Days)
- ALLR 2.6M
- SPRC 6.1M
- Earning Date
- ALLR 05-13-2025
- SPRC 02-15-2025
- Dividend Yield
- ALLR N/A
- SPRC N/A
- EPS Growth
- ALLR N/A
- SPRC N/A
- EPS
- ALLR N/A
- SPRC N/A
- Revenue
- ALLR N/A
- SPRC $1,747,000.00
- Revenue This Year
- ALLR N/A
- SPRC N/A
- Revenue Next Year
- ALLR N/A
- SPRC N/A
- P/E Ratio
- ALLR N/A
- SPRC N/A
- Revenue Growth
- ALLR N/A
- SPRC N/A
- 52 Week Low
- ALLR $0.68
- SPRC $0.20
- 52 Week High
- ALLR $174.00
- SPRC $2.10
- Technical
- Relative Strength Index (RSI)
- ALLR 37.39
- SPRC 36.90
- Support Level
- ALLR $0.91
- SPRC $0.30
- Resistance Level
- ALLR $1.23
- SPRC $0.32
- Average True Range (ATR)
- ALLR 0.14
- SPRC 0.03
- MACD
- ALLR -0.02
- SPRC 0.00
- Stochastic Oscillator
- ALLR 3.15
- SPRC 15.17
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.